Increased number of CD34+cells in nasal mucosa of allergic rhinitis patients: inhibition by a local corticosteroid
- 10 September 2004
- journal article
- clinical trial
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 35 (1) , 34-38
Abstract
Summary: Background Eosinophils develop from CD34+ haematopoietic progenitor cells. Allergen exposure in susceptible individuals is known to induce a local eosinophilic inflammation, but the effect on progenitor cells is much less understood.Objective We aimed to evaluate how allergen exposure affects the number of tissue CD34+ cells and CD34+ eosinophils in allergic rhinitis (AR) patients and whether any such effect is influenced by local corticosteroid treatment. Also, we evaluated changes in the number of CXC receptor 4‐positive cells (CXCR4+), since the CXCR4 ligand (stromal cell‐derived factor‐1 (SDF‐1)) is a potent chemoattractant for haematopoietic progenitors.Methods In a double‐blind, randomized study, pollen‐sensitized AR patients were treated with a nasal corticosteroid fluticasone propionate (FP, 200 μg/day) or placebo throughout the pollen season. Nasal biopsies were taken before and during the season. CD34 and CXCR4 were stained using immunohistochemistry.Results The pollen season significantly increased the number of CD34+ cells, CD34+/CXCR4+ cells and CD34+ eosinophils in placebo‐treated patients, but not in FP‐treated patients. The mean pollen season‐induced increase in CD34+ cells, CD34+/CXCR4+ cells and CD34+ eosinophils in FP‐treated patients was lower compared with placebo‐treated patients.Conclusion A pollen season increases the number of CD34+ cells in nasal tissue accompanied by an increase in the number of CD34+/CXCR4+ haematopoietic progenitors and also the number of CD34+ eosinophils in subjects with AR. Treatment with a local corticosteroid provides protection against this pollen‐induced increase in tissue CD34+ cells and CD34+ eosinophils possibly via inhibition of allergen‐induced CXCR4‐mediated recruitment of CD34+ haematopoietic progenitors into airways and their further differentiation into eosinophils within the tissue.Keywords
This publication has 14 references indexed in Scilit:
- Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitisJournal of Allergy and Clinical Immunology, 2002
- Hematopoietic Stem Cells Are Uniquely Selective in Their Migratory Response to ChemokinesJournal of Experimental Medicine, 2002
- The Effects of Inhaled Budesonide on Circulating Eosinophil Progenitors and Their Expression of Cytokines after Allergen Challenge in Subjects with Atopic AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2000
- An Inhaled Corticosteroid, Budesonide, Reduces Baseline but Not Allergen-induced Increases in Bone Marrow Inflammatory Cell Progenitors in Asthmatic SubjectsAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Immunolocalization of CD34 in Nasal Polyposis: Effect of Topical CorticosteroidsAmerican Journal of Respiratory Cell and Molecular Biology, 1999
- Allergen Challenge Increases Cell Traffic between Bone Marrow and LungAmerican Journal of Respiratory Cell and Molecular Biology, 1998
- Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar developmentNature, 1998
- The Chemokine SDF-1 Is a Chemoattractant for Human CD34+ Hematopoietic Progenitor Cells and Provides a New Mechanism to Explain the Mobilization of CD34+ Progenitors to Peripheral BloodJournal of Experimental Medicine, 1997
- Allergen-Induced Changes in Bone Marrow Progenitors and Airway Responsiveness in Dogs and the Effect of Inhaled Budesonide on These ParametersAmerican Journal of Respiratory Cell and Molecular Biology, 1994
- Expression of the CD34 gene in vascular endothelial cellsBlood, 1990